Vorsetuzumab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Target | CD70 |
| Identifiers | |
| CAS Number | 1165740-62-4 |
| ATC code | none |
| Chemical data | |
| Formula | C6476H10006N1726O2028S50 |
| Molecular mass | 146.1 kg/mol |
Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics, designed for the treatment of cancer.[1]
Chemical names are:
- Immunoglobulin G1, anti-(CD antigen CD70) (human-mouse monoclonal h1F6 heavy chain), disulfide with human-mouse monoclonal h1F6 light chain, dimer
- Immunoglobulin G1, anti-(human CD70 antigen (CD27 ligand, Tumor necrosis
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Monoclonal antibodies
- Monoclonal antibody stubs
